Cyclo Therapeutics- Warrants (14/11/2025) Common Stock

As of the most recent data (September 2024), CYTHW shows a common stock of $2.9K. That compares with $1.9K in the prior-year period — up 48.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTHW's common stock is now $2.9K (was $1.9K) — a 48.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclo Therapeutics- Warrants (14/11/2025) is outperforming or lagging.

Tracking CYTHW's common stock over time shows whether Cyclo Therapeutics- Warrants (14/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.9K That compares with $1.9K in the prior-year period — up 48.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Cyclo Therapeutics- Warrants (14/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $2.9K) with ownership activity and broader fundamentals.

Cyclo Therapeutics- Warrants (14/11/2025)'s common stock is $2.9K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.